Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency

Detalhes bibliográficos
Autor(a) principal: Gonçalves, Jean-Pierre
Data de Publicação: 2014
Outros Autores: Correia, Filipa, Cardoso, Helena, Borges, Teresa, Oliveira, Maria João
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878
Resumo: Introduction: The incidence of short stature associated with growth hormone deficiency has been estimated to be about 1:4000 to 1:10000. It is the main indication for treatment with recombinant growth hormone.Objectives: The aims of the study were to evaluate the results of growth hormone stimulation tests and identify the growth hormone deficiency predictors.Material and Methods: A cross-sectional, analytical and observational study was conducted. We studied all the children and adolescents submitted to growth hormone pharmacological stimulation tests between January 2008 and May 2012. Growth hormone deficiency diagnosis was confirmed by two negatives growth hormone stimulation tests (growth hormone peak < 7 ng/ml). The statistical analysis was performed using student t-test, chi-square, Pearson correlation and logistic regression. Statistical significance determined at the 5% level (p ≤ 0.05).Results: Pharmacological stimulation tests were performed in 89 patients, with a median age of 10 [3-17] years. Clonidine (n = 85) and insulin tolerance test (n = 4) were the first growth hormone stimulation tests performed. Growth hormone deficiency was confirmed in 22 cases. In cases with two growth hormone stimulation tests, the growth hormone peak showed a moderate correlation (r = 0.593, p = 0.01). In logistic regression model height (z-score) and the growth hormone peak in first stimulation test were predictors of growth hormone deficiency diagnosis (each one unit increase in z-score decrease the growth hormone deficiency probability).Discussion: Measurement of IGF-1 cannot be used in diagnosing growth hormone deficiency.Conclusion: Auxological criteria associated with a positive test seems to be a reliable diagnostic tool for growth hormone deficiency.Keywords: Growth Disorders; Human Growth Hormone/blood.
id RCAP_cec14b75df7e9230615083a6e2c7951b
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/4878
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone InsufficiencyO Papel dos Testes de Estimulação Farmacológica no Diagnóstico da Deficiência de Hormona do Crescimento em Crianças e AdolescentesIntroduction: The incidence of short stature associated with growth hormone deficiency has been estimated to be about 1:4000 to 1:10000. It is the main indication for treatment with recombinant growth hormone.Objectives: The aims of the study were to evaluate the results of growth hormone stimulation tests and identify the growth hormone deficiency predictors.Material and Methods: A cross-sectional, analytical and observational study was conducted. We studied all the children and adolescents submitted to growth hormone pharmacological stimulation tests between January 2008 and May 2012. Growth hormone deficiency diagnosis was confirmed by two negatives growth hormone stimulation tests (growth hormone peak < 7 ng/ml). The statistical analysis was performed using student t-test, chi-square, Pearson correlation and logistic regression. Statistical significance determined at the 5% level (p ≤ 0.05).Results: Pharmacological stimulation tests were performed in 89 patients, with a median age of 10 [3-17] years. Clonidine (n = 85) and insulin tolerance test (n = 4) were the first growth hormone stimulation tests performed. Growth hormone deficiency was confirmed in 22 cases. In cases with two growth hormone stimulation tests, the growth hormone peak showed a moderate correlation (r = 0.593, p = 0.01). In logistic regression model height (z-score) and the growth hormone peak in first stimulation test were predictors of growth hormone deficiency diagnosis (each one unit increase in z-score decrease the growth hormone deficiency probability).Discussion: Measurement of IGF-1 cannot be used in diagnosing growth hormone deficiency.Conclusion: Auxological criteria associated with a positive test seems to be a reliable diagnostic tool for growth hormone deficiency.Keywords: Growth Disorders; Human Growth Hormone/blood.Introdução: A incidência da deficiência de hormona do crescimento é de 1:4000 a 1:10000, sendo a principal indicação para tratamento com hormona do crescimento recombinante.Objectivos: Avaliar os resultados dos testes de estimulação da hormona do crescimento e identificar factores preditivos para o diagnóstico da deficiência de hormona do crescimento.Material e Métodos: Estudo observacional, analítico e transversal. Foram analisados dados clínicos e auxológicos e os resultados dos exames de diagnóstico de crianças e adolescentes submetidos a testes de estimulação farmacológica da hormona do crescimento (01/01/2008 a 31/05/2012). O diagnóstico definitivo de deficiência de hormona do crescimento foi efectuado mediante dois testes com estímulos farmacológicos diferentes negativos (pico máximo da hormona do crescimento < 7 ng/mL) ou um teste negativo associado à presença de alterações anatómicas da região hipotálamo-hipofisária, observadas na ressonância magnética cerebral. Para análise estatística, foram realizados o testes de t student, do qui- quadrado, correlação de Pearson e a regressão logística. Foi considerado como nível de significância estatística (p) um valor igual ou menor que 0,05.Resultados: Realizaram-se testes de estimulação em 89 doentes, com mediana de idade igual a 10 [3-17] anos, 67% do sexo masculino e 77% pré-púberes. Os fármacos utilizados no primeiro teste de estimulação foram a clonidina (n = 85) e a insulina (n = 4). Foram diagnosticados 22 casos de deficiência de hormona do crescimento. Nos casos submetidos a dois testes, os valores máximos de hormona do crescimento apresentaram uma correlação moderada entre si (r = 0,593, p = 0,01). Verificou-se que as variáveis estatura (z-score) e pico máximo de hormona do crescimento obtido no primeiro teste têm valor preditivo no diagnóstico de deficiência de hormona do crescimento.Discussão: A determinação do IGF-1 não demonstrou ser preditor de deficiência de hormona do crescimento.Conclusão: Os testes de estimulação são uma ferramenta de diagnóstico da deficiência de hormona do crescimento e que devem ser enquadrados nos parâmetros clínicos e auxológicos.Palavras-chave: Alterações do Crescimento; Hormona do Crescimento Humano.Ordem dos Médicos2014-09-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878oai:ojs.www.actamedicaportuguesa.com:article/4878Acta Médica Portuguesa; Vol. 27 No. 5 (2014): September-October; 587-592Acta Médica Portuguesa; Vol. 27 N.º 5 (2014): Setembro-Outubro; 587-5921646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878/4059https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878/4183https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878/7299https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878/7300Gonçalves, Jean-PierreCorreia, FilipaCardoso, HelenaBorges, TeresaOliveira, Maria Joãoinfo:eu-repo/semantics/openAccess2022-12-20T11:04:03Zoai:ojs.www.actamedicaportuguesa.com:article/4878Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:18:59.699299Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency
O Papel dos Testes de Estimulação Farmacológica no Diagnóstico da Deficiência de Hormona do Crescimento em Crianças e Adolescentes
title Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency
spellingShingle Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency
Gonçalves, Jean-Pierre
title_short Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency
title_full Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency
title_fullStr Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency
title_full_unstemmed Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency
title_sort Provocative Tests in the Diagnosis of Childhood Onset Growth Hormone Insufficiency
author Gonçalves, Jean-Pierre
author_facet Gonçalves, Jean-Pierre
Correia, Filipa
Cardoso, Helena
Borges, Teresa
Oliveira, Maria João
author_role author
author2 Correia, Filipa
Cardoso, Helena
Borges, Teresa
Oliveira, Maria João
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Gonçalves, Jean-Pierre
Correia, Filipa
Cardoso, Helena
Borges, Teresa
Oliveira, Maria João
description Introduction: The incidence of short stature associated with growth hormone deficiency has been estimated to be about 1:4000 to 1:10000. It is the main indication for treatment with recombinant growth hormone.Objectives: The aims of the study were to evaluate the results of growth hormone stimulation tests and identify the growth hormone deficiency predictors.Material and Methods: A cross-sectional, analytical and observational study was conducted. We studied all the children and adolescents submitted to growth hormone pharmacological stimulation tests between January 2008 and May 2012. Growth hormone deficiency diagnosis was confirmed by two negatives growth hormone stimulation tests (growth hormone peak < 7 ng/ml). The statistical analysis was performed using student t-test, chi-square, Pearson correlation and logistic regression. Statistical significance determined at the 5% level (p ≤ 0.05).Results: Pharmacological stimulation tests were performed in 89 patients, with a median age of 10 [3-17] years. Clonidine (n = 85) and insulin tolerance test (n = 4) were the first growth hormone stimulation tests performed. Growth hormone deficiency was confirmed in 22 cases. In cases with two growth hormone stimulation tests, the growth hormone peak showed a moderate correlation (r = 0.593, p = 0.01). In logistic regression model height (z-score) and the growth hormone peak in first stimulation test were predictors of growth hormone deficiency diagnosis (each one unit increase in z-score decrease the growth hormone deficiency probability).Discussion: Measurement of IGF-1 cannot be used in diagnosing growth hormone deficiency.Conclusion: Auxological criteria associated with a positive test seems to be a reliable diagnostic tool for growth hormone deficiency.Keywords: Growth Disorders; Human Growth Hormone/blood.
publishDate 2014
dc.date.none.fl_str_mv 2014-09-25
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878
oai:ojs.www.actamedicaportuguesa.com:article/4878
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/4878
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878/4059
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878/4183
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878/7299
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4878/7300
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 27 No. 5 (2014): September-October; 587-592
Acta Médica Portuguesa; Vol. 27 N.º 5 (2014): Setembro-Outubro; 587-592
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130641342660608